Blee vs Manus AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI marketing compliance review platform for financial services and healthcare automating FINRA and FDA regulatory checks; $2.8M from YC and Finovate achieving $1.5M revenue competing with Smarsh.
About
Blee is a New York-based AI compliance review platform for marketing content in financial services and healthcare — automating the review of ads, social media posts, email campaigns, and marketing materials against regulatory requirements (FINRA, SEC, FDA, FTC) and company-specific compliance policies, replacing the manual compliance queue that creates weeks-long bottlenecks between marketing creation and publication. Founded in 2022 and a Y Combinator S22 graduate, Blee raised $2.8 million from Finovate, Cardumen Capital, and Y Combinator, and achieved $1.5 million in revenue in 2024 with a 7-10 person team.
General-purpose autonomous AI agent. $125M+ revenue run rate. Acquired by Meta for $2B+ (Dec 2025). Founded 2022, China/Singapore. MIT Innovators Under 35.
About
Manus AI is a general-purpose autonomous AI agent developed by Butterfly Effect Pte Ltd, founded in 2022 by Yichao "Peak" Ji and Xiao Hong. Relocated from China to Singapore (mid-2025). Launched March 6, 2025, autonomously handling complex tasks like market research, coding, data analysis, and content creation without human intervention.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.